Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
Dr. Reddy’s Achieves Highest-Ever Quarterly Revenue in Q1, Demonstrating Consistent Performance Amidst Ongoing Transition.

Dr. Reddy’s Achieves Highest-Ever Quarterly Revenue in Q1, Demonstrating Consistent Performance Amidst Ongoing Transition.

by Team Small News | Aug 5, 2025 | Dr Reddy's

To access targeted data for a specific country, users can switch the Market flag to their country of choice. This is achieved by opening the menu and selecting the desired country from the available options. By doing so, users can view data that is tailored to their...

Global Digoxin Industry Analysis: An In-Depth Report Featuring Key Players Such as Pfizer, Novartis, and Mylan

by Team Small News | Jul 12, 2025 | Cipla, Dr Reddy's, Lupin, Pfizer, Pharma

The Global Digoxin Market study, recently introduced by HTF MI, provides a comprehensive overview of the product and industry scope, as well as an in-depth analysis of the market outlook and status from 2025 to 2031. The market is segmented by key regions, including...
Dr. Reddy’s Achieves Highest-Ever Quarterly Revenue in Q1, Demonstrating Consistent Performance Amidst Ongoing Transition.

Dr Reddy’s gears up to tackle potential hurdles in the US market during the fourth quarter.

by Team Small News | Jul 2, 2025 | Dr Reddy's

Dr. Reddy’s Laboratories, a leading pharmaceutical company, is gearing up to face challenges in the US market, particularly in the fourth quarter of the current fiscal year. The company’s Chairman, K Satish Reddy, and Co-Chairman and Managing Director, GV...
Dr. Reddy’s Achieves Highest-Ever Quarterly Revenue in Q1, Demonstrating Consistent Performance Amidst Ongoing Transition.

Alvotech and Dr. Reddy’s have formed a partnership to create a biosimilar version of the cancer treatment Pembrolizumab.

by Team Small News | Jun 20, 2025 | Dr Reddy's

Alvotech, a global biopharmaceutical company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar for Pembrolizumab, a cancer drug used to treat various types of cancer, including melanoma, lung...
Dr. Reddy’s Achieves Highest-Ever Quarterly Revenue in Q1, Demonstrating Consistent Performance Amidst Ongoing Transition.

Alvotech and Dr. Reddy’s collaborate to create a biosimilar version of the cancer treatment Pembrolizumab.

by Team Small News | Jun 17, 2025 | Dr Reddy's

Alvotech, a global biopharmaceutical company, has partnered with Dr. Reddy’s Laboratories, a leading pharmaceutical company, to develop a biosimilar for the cancer drug pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a monoclonal...
Dr. Reddy’s Achieves Highest-Ever Quarterly Revenue in Q1, Demonstrating Consistent Performance Amidst Ongoing Transition.

Eight individuals were detained for allegedly stealing medications valued at ₹2 crore from Dr Reddy’s Laboratory.

by Team Small News | Jun 16, 2025 | Dr Reddy's

In a significant breakthrough, the JR Puram police in Srikakulam have arrested a gang of eight individuals, including employees of top pharmaceutical firms, for stealing Semaglutide, a valuable anti-diabetic and weight-loss medicine, from Dr. Reddy’s...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress